Jama Network

  • Autor: Vários
  • Narrador: Vários
  • Editor: Podcast
  • Duración: 57:48:51
  • Mas informaciones

Informações:

Sinopsis

Audio Interviews with Authors of articles in the JAMA Network Specialty Journals

Episodios

  • JAMA Neurology : Risk Factors for Young-Onset Dementia in the UK Biobank

    26/12/2023 Duración: 14min

    Interview with Stevie Hendriks, PhD, author of Risk Factors for Young-Onset Dementia in the UK Biobank. Hosted by Cynthia E. Armand, MD. Related Content: Risk Factors for Young-Onset Dementia in the UK Biobank

  • JAMA Surgery : Preoperative Midazolam and Patient-Centered Outcomes of Older Patients

    20/12/2023 Duración: 14min

    Interview with Mark Coburn, MD, and Ana Kowark, MD, authors of Preoperative Midazolam and Patient-Centered Outcomes of Older Patients: The I-PROMOTE Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Preoperative Midazolam and Patient-Centered Outcomes of Older Patients

  • JAMA Internal Medicine : Association Between Daily Toothbrushing and Hospital-Acquired Pneumonia

    18/12/2023 Duración: 13min

    Interview with Michael Klompas, MD, MPH, author of Association Between Daily Toothbrushing and Hospital-Acquired Pneumonia: A Systematic Review and Meta-Analysis, and Rupak Datta, MD, PhD, author of Daily Toothbrushing to Prevent Hospital-Acquired Pneumonia—Brushing Away the Risk. Hosted by Louise Aronson, MD, MFA. Related Content: Association Between Daily Toothbrushing and Hospital-Acquired Pneumonia Daily Toothbrushing to Prevent Hospital-Acquired Pneumonia—Brushing Away the Risk

  • JAMA Oncology : Atezolizumab in Combination With Carboplatin in Metastatic TNBC

    14/12/2023 Duración: 18min

    Interview with Jennifer A. Pietenpol, PhD, Brian D. Lehmann, PhD, and Vandana G. Abramson, MD, authors of Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer: The TBCRC 043 Phase 2 Randomized Clinical Trial. Hosted by Mary L. (Nora) Disis, MD. Related Content: Atezolizumab in Combination With Carboplatin and Survival Outcomes in Patients With Metastatic Triple-Negative Breast Cancer

  • JAMA Psychiatry : Transdiagnostic Ecological Momentary Intervention for Improving Self-Esteem in Youth Exposed to Childhood Adversity

    29/11/2023 Duración: 23min

    Interview with Ulrich Reininghaus, PhD, author of Transdiagnostic Ecological Momentary Intervention for Improving Self-Esteem in Youth Exposed to Childhood Adversity: The SELFIE Randomized Clinical Trial. Hosted by John Torous, MD, MBI. Related Content: Transdiagnostic Ecological Momentary Intervention for Improving Self-Esteem in Youth Exposed to Childhood Adversity

  • JAMA Neurology : Endovascular Therapy Outcomes by ASPECTS and Infarct Core Volume in Patients With Large Infarct

    27/11/2023 Duración: 14min

    Interview with Zhongrong Miao, MD, author of Alberta Stroke Program Early Computed Tomography Score, Infarct Core Volume, and Endovascular Therapy Outcomes in Patients With Large Infarct: A Secondary Analysis of the ANGEL-ASPECT Trial. Hosted by Cynthia E. Armand, MD. Read Transcript Related Content:   Alberta Stroke Program Early Computed Tomography Score, Infarct Core Volume, and Endovascular Therapy Outcomes in Patients With Large Infarct

  • JAMA Otolaryngology–Head & Neck Surgery : Liquid Biopsies for Head and Neck Cancers

    16/11/2023 Duración: 14min

    Interview with Michael J. Brenner, MD, author of Liquid Biopsies for Head and Neck Cancers—Any Hope for Human Papillomavirus–Negative Disease? Hosted by Paul C. Bryson, MD, MBA. Related Content: Liquid Biopsies for Head and Neck Cancers—Any Hope for Human Papillomavirus–Negative Disease?

  • JAMA Ophthalmology : Social Determinants of Health and Perceived Barriers to Care in Diabetic Retinopathy Screening

    16/11/2023 Duración: 15min

    Interview with Sophia Y. Wang, MD, MS, author of Social Determinants of Health and Perceived Barriers to Care in Diabetic Retinopathy Screening. Hosted by Neil Bressler, MD. Related Content: Social Determinants of Health and Perceived Barriers to Care in Diabetic Retinopathy Screening

  • JAMA Surgery : Operative vs Nonoperative Management of Acute Cholecystitis During the Different Trimesters of Pregnancy

    15/11/2023 Duración: 16min

    Interview with Mariam N. Hantouli, MD, and Giana H. Davidson, MD, MPH, authors of Operative vs Nonoperative Management of Acute Cholecystitis During the Different Trimesters of Pregnancy. Hosted by Amalia Cochran, MD. Related Content: Operative vs Nonoperative Management of Acute Cholecystitis During the Different Trimesters of Pregnancy

  • JAMA Cardiology : Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy

    15/11/2023 Duración: 21min

    Interview with Sanjiv J. Shah, MD, author of Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial. Hosted by James E. Udelson, MD. Related Content: Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy

  • JAMA Dermatology : Pathologist Characteristics and Higher-Grade Diagnoses for Melanocytic Lesions

    08/11/2023 Duración: 18min

    Interview with Kathleen F. Kerr, PhD, author of Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions

  • JAMA Neurology : Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis

    06/11/2023 Duración: 19min

    Interview with Ari J. Green, MD, author of Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis. Hosted by Cynthia E. Armand, MD. Related Content: Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis

  • JAMA Internal Medicine : Overnight Stay in the Emergency Department and Mortality in Older Patients

    06/11/2023 Duración: 15min

    Interview with Yonathan Freund, MD, PhD, author of Overnight Stay in the Emergency Department and Mortality in Older Patients, and Timothy S. Anderson, MD, MAS, author of The Risks of Being in Limbo in the Emergency Department. Hosted by Louise Aronson, MD, MFA. Related Content: Overnight Stay in the Emergency Department and Mortality in Older Patients The Risks of Being in Limbo in the Emergency Department

  • JAMA Neurology : Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel Disease

    30/10/2023 Duración: 17min

    Interview with Richard A. Bernstein, MD, PhD, author of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: 3-Year Results From the STROKE AF Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Atrial Fibrillation In Patients With Stroke Attributed to Large- or Small-Vessel Disease

  • JAMA Internal Medicine : Nurse Care Management for Opioid Use Disorder Treatment

    30/10/2023 Duración: 18min

    Interview with Katharine A. Bradley, MD, MPH, author of Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial, and Michael A. Incze, MD, MSEd, and Deborah S. Finnell, PhD, RN, authors of Amplifying the Strength and Leadership of Nurses in Opioid Use Disorder Care—Loud and PROUD. Hosted by Louise Aronson, MD, MFA. Related Content: Nurse Care Management for Opioid Use Disorder Treatment Amplifying the Strength and Leadership of Nurses in Opioid Use Disorder Care—Loud and PROUD

  • JAMA Ophthalmology : Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion

    26/10/2023 Duración: 16min

    Interview with Prithvi Mruthyunjaya, MD, MHS, author of Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion. Hosted by Neil M. Bressler, MD. Related Content: Risk of Stroke, Myocardial Infarction, and Death After Retinal Artery Occlusion

  • JAMA Cardiology : Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction

    25/10/2023 Duración: 20min

    Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD. Related Content: Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive

  • JAMA Dermatology : Patient Perspectives on Social Risk Screening and Documentation

    25/10/2023 Duración: 17min

    Interview with Aileen Y. Chang, MD, author of Patient Perspectives on Social Risk Screening and Documentation in a Dermatology Clinic. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Patient Perspectives on Social Risk Screening and Documentation in a Dermatology Clinic

  • JAMA Psychiatry : Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With ADHD

    25/10/2023 Duración: 19min

    Interview with Michael H. Bloch, MD, MS, and Samuele Cortese, MD, PhD, authors of Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. Hosted by John Torous, MD, MBI. Related Content: Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder

  • JAMA Surgery : Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS

    23/10/2023 Duración: 19min

    Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD. Related Content: Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ

página 10 de 10